Wednesday, October 04, 2017
Webinar: Navigating the FDA Communications Guidances: Best Practices
12:00 PM - 01:00 PM
Please join us for a complimentary Webinar (Web-based seminar produced through Adobe Connect) sponsored by the IADC Drug, Device and Biotechnology Committee and Product Liability Committee on Wednesday, October 4, 2017 for one (1) hour beginning at:
10:00 AM PDT / 11:00 AM MDT / 12:00 PM Noon CDT / 1:00 PM EDT
Click here to register
Navigating the FDA Communications Guidances: Best Practices for Pharmaceutical Sales and Marketing Communications with Physicians
This Webinar will focus on how pharmaceutical, biologic, and medical device companies, including sales and marketing professionals and detail representatives, communicate about their products. In 2017, the FDA published draft guidances and rules on the First Amendment and "intended use," which is the basis for determining whether a product is regulated by the FDA. As sales and marketing witnesses are thrown to the forefront of products liability litigation, their communications with physicians often become the subject of depositions and trial testimony. This Webinar explores acceptable communications, FDA rules, risk assessment, First Amendment implications, and how to prepare for deposition and trial.
For more information, click here.
For information on any Webinar, please visit the Webinar page on the IADC website.
Export to Outlook